Congenital Portosystemic Shunting: A Wilson’s Disease Mimic
Objective: To report a patient with a congenital extrahepatic portosystemic shunt with features mimicking those seen in Wilson’s disease Background: Wilson’s disease is an autosomal recessive disorder caused by…Study Of Epidemiological and Clinical Profile of Neurologic Wilson’s Disease from a Tertiary Care Hospital In India
Objective: To study the epidemiological profile of neurologic Wilson’s disease (WD) and to study clinical, biochemical and radiological features of neurologic WD Background: Wilson’s disease…A Case of Concurrent Wilson Disease and Parkinson Disease
Objective: to present a case of concurrent Wilson disease and Parkinson disease. Background: Wilson disease (WD) is a rare autosomal recessive disease that typically manifests…A Curious Case of Copper de-Compensation
Objective: To describe the investigation and management of a patient with Wilson’s disease who experienced late-onset neurological deterioration despite continued treatment. Background: Wilson’s disease is…Wilson’s Disease : A Senegalese Series of Seven Patients Followed at Pikine National Hospital Centre (Dakar-Senegal)
Objective: The aim of this study is to describe the epidemiological, diagnostic, therapeutic and evolutionary characteristics of Wilson's disease and to highlight the diagnostic and…Real-life experience of switching from D-penicillamine to trientine tetrahydrochloride – a nationwide registry study
Objective: Our aim was to assess the efficacy and safety of trientine tetrahydrochloride (TETA4HCL) in a cohort of neurological Wilson's disease (WD) patients transitioned from…Transition from Zinc Salts to Trientine Tetrahydrochloride in Wilson Disease: Clinical and Biochemical Effects over Two Years – the ZICUP study
Objective: To assess the clinical and biochemical effects of transitioning from zinc salts (ZS) to trientine tetrahydrochloride (TETA4HCL) in Wilson disease (WD) patients over a…Prevalence of immune-mediated diseases in long-term chelator therapy in Wilson’s Disease
Objective: To determine the prevalence of concurrent immune-mediated diseases during copper chelation therapy in Wilson’s disease (WD). Background: Wilson’s disease is a neurometabolic autosomal recessive…Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease
Objective: To determine the frequency of side effects of long-term copper chelation therapy in Wilson’s disease (WD). Background: WD is a neurometabolic autosomal recessive disorder…Late-onset neurologic Wilson’s disease: case series
Objective: To report the case series of patients with late-onset Wilson’s disease (WD) with predominantly neurological manifestation. Background: WD is a rare and treatable disorder…
- 1
- 2
- 3
- 4
- Next Page »